New Version of Inhaled Antibiotic for Infections in Bronchiectasis, CF Being Developed
Bronchiectasis, News
Basilea Pharmaceutica Ltd. recently announced the development of an inhaled formulation of a new antibiotic called BAL30072 that may facilitate treatment of patients with cystic fibrosis and bronchiectasis. Cystic fibrosis is ... Read more